Verastem (VSTM)
(Real Time Quote from BATS)
$2.74 USD
-0.14 (-4.86%)
Updated Sep 23, 2024 12:10 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Verastem, Inc. [VSTM]
Reports for Purchase
Showing records 1 - 20 ( 267 total )
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
LGSOC NDA Submission Underway; Adjust PT to $7.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Promising Early Pancreatic Results Despite Toxicity Concerns; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
LGSOC Topline Results and NDA Submission Expected in Q2; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on LGSOC NDA Submission and Program Updates; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 1224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 12223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
LGSOC NDA Submission Expected in 1H24; Phase 3 Ready to Start; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
RAMP 201 Study Update at IGCS 2023 Conference; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 102123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 82123
Provider: Stock Traders Daily
Analyst: Research Department